Nasdaq
CTMX
CytomX Therapeutics, Inc.
- Health Care
- Listed 2015
- 1 day
- +0.6%
- 1 month
- −12.2%
- 1 year
- +55.3%
$3.37 · Mkt cap $734M
At the 6 Aug 2026 close
Nasdaq
CytomX Therapeutics, Inc.
$3.37 · Mkt cap $734M
At the 6 Aug 2026 close
CytomX Therapeutics, Inc. trades under the ticker CTMX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2015. Its market capitalisation is $734M. The last closing price was $3.37, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +55.3%, and −12.2% over the past month. Returns are price returns and exclude dividends.
This page exists because CTMX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.